معرفی
Scientia Professor Vlado Perkovic serves as the Provost at UNSW Sydney, having previously held the position of Dean of the Faculty of Medicine and Health at the same institution. He is also a Professorial Fellow at The George Institute for Global Health and was formerly a Staff Specialist in Nephrology at the Royal North Shore Hospital. Professor Perkovic completed his undergraduate medical training at The Royal Melbourne Hospital and earned his Doctor of Philosophy from the University of Melbourne.
Professor Perkovic is a leading researcher in clinical trials and epidemiology, with a specialized focus on preventing the progression of kidney disease and its complications. His work has significantly influenced clinical practice through major international clinical trials and contributions to Australian and global guidelines in kidney disease, cardiovascular risk assessment, and blood pressure management. His research spans clinical trial methodology, epidemiology of kidney disease, diabetes complications, and implementation of evidence-based medicine.
Analysis of his recent publications reveals a strong emphasis on combination therapies for kidney protection, population-level impacts of novel medications like SGLT2 inhibitors, and long-term benefits of cardiovascular and renal protective agents. His work frequently involves large-scale clinical trial data analysis, particularly from the CANVAS Program and CREDENCE trial, which have shaped treatment approaches for patients with diabetes and chronic kidney disease worldwide.
- Fellow of the Royal Australasian College of Physicians
- Fellow of the Australian Academy of Health and Medical Sciences
- Fellow of the American Society of Nephrology
Professor Perkovic has secured substantial research funding and has mentored numerous students and early-career researchers in nephrology. His leadership extends beyond research to academic administration and healthcare policy development. As Provost, he plays a key role in shaping the academic direction of UNSW while maintaining active involvement in clinical research that continues to influence global kidney disease management.
